Compound ID	CDAMM00899
Common name	(3S,7E,9S)-9-Hydroxy-4,7-megastigmadien-3-one 9-glucoside
IUPAC name	3,5,5-trimethyl-4-[3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybut-1-enyl]cyclohex-2-en-1-one
Molecular formula	C₁₉H₃₀O₇

Experimental data

Retention time	11.81
Adduct	[M+H]+
Actual mz	371.209
Theoretical mz	371.206
Error	6.26
Ionizaton mode	Positive
Instrument type	LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score	7.3424

Identifiers and class information

Inchi key	SZOPSAFLRCYJCX-AATRIKPKNA-N
Smiles	O=C1C=C(C)C(C=CC(OC2OC(CO)C(O)C(O)C2O)C)C(C)(C)C1
Superclass	Lipids and lipid-like molecules
Class	Fatty Acyls

Plant source

Cinnamomum verum J. Presl

Curcuma longa L.

External sources

HMDB ID	HMDB0036822
KNApSAcK ID	C00040935
FooDB ID	FDB015770
DrugBank ID
ChEBI ID
Pubchem Compound ID	73815024
PlantCyc ID
UNPD ID	UNPD159381
Coconut ID	CNP0289995
LipidMAPS ID
NANPDB ID

Pharmacokinetic properties

Number of descriptor values(#stars)	0
Number of non-conjugated amine groups (#amine)	0
Number of amidine and guanidine groups (#amidine)	0
Number of carboxylic acid groups (#acid)	0
Number of non-conjugated amide groups (#amide)	0
Number of rotatable bonds (#rotor)	9
Number of reactive functional groups (#rtvFG)	1
Predicted central nervous system activity (CNS)	-2
Molecular weight (mol_MW)	370.442
Computed dipole moment(dipole)	4.711
Total solvent accessible surface area (SASA)	602.628
Hydrophobic component of SASA (FOSA)	378.066
Hydrophilic component of SASA (FISA)	212.35
Pie component of the SASA (PISA)	12.212
Weakly polar component of the SASA (WPSA)	0
Total solvent accesible volume (volume)	1153.63
Number of hydrogen bond donors (donorHB)	4
Number of hydrogen bond acceptors (accptHB)	12.2
Free energy of solvation of dipole (dip^2/V)	0.0192377
Index of cohesive interaction in solids (ACxDN^.5/SA)	0.0404893
Globularity descriptor (glob)	0.882726
Predicted polarizability in cubic angstroms (QPpolrz)	34.352
Predicted hexadecane/gas partition coefficient (QPlogPC16)	11.508
Predicted octanol/gas partition coefficient (QPlogPoct)	23.951
Predicted water/gas partition coefficient (QPlogPw)	18.587
Predicted octanol/water partition coefficient (QPlogPo/w)	0.021
Predicted aqueous solubility (QPlogS)	-2.225
Conformation-independent predicted aqueous solubility (CIQPlogS)	-2.274
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)	-3.488
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)	95.982
Predicted brain/blood partition coefficient (QPlogBB)	-1.796
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)	39.284
Predicted skin permeability, log Kp (QPlogKp)	-4.526
PM3 calculated ionization potential (IP(ev))	10.235
PM3 calculated electron affinity (EA(eV))	0.314
Number of likely metabolic reactions (#metab)	8
Prediction of binding to human serum albumin (QPlogKhsa)	-0.661
Predicted qualitative human oral absorption (HumanOralAbsorption)	2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)	62.546
Solvent-accessible surface area of fluorine atoms (SAFluorine)	0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)	0
Van der Waals surface area (PSA)	129.078
Number of nitrogen and oxygen atoms (#NandO)	7
Number of violations of Lipinski’s rule of five (RuleOfFive)	0
Number of violations of Jorgensen’s rule of three (RuleOfThree)	1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID	Gene name	Target name	TTD_ID	Prediction source
P15692	VEGFA	Vascular endothelial growth factor A	T20761	SEA
P05230	FGF1	Acidic fibroblast growth factor	T18639	SEA
P09038	FGF2	Basic fibroblast growth factor	T31621	SEA
P60568	IL2	Interleukin-2	T61698	SEA
P17931	LGALS3	Galectin-3	T72038	SEA
P14679	TYR	Tyrosinase	T97035	SEA
Q9NZ08	ERAP1	Endoplasmic reticulum aminopeptidase 1	T72849	SEA

Target associated diseases

TTD_ID	Disease_ID	Disease name	ICD_11	Uniprot ID	Gene names
T20761	DI0095	Colorectal cancer	[ICD-11: 2B91]	P15692	VEGFA
T20761	DI0365	Retinopathy	[ICD-11: 9B71]	P15692	VEGFA
T20761	DI0430	Vascular system developmental anomaly	[ICD-11: LA90]	P15692	VEGFA
T18639	DI0081	Chronic arterial occlusive disease	[ICD-11: BD4Z]	P05230	FGF1
T18639	DI0102	Coronary atherosclerosis	[ICD-11: BA52]	P05230	FGF1
T31621	DI0005	Acne vulgaris	[ICD-11: ED80]	P09038	FGF2
T61698	DI0275	Multiple sclerosis	[ICD-11: 8A40]	P60568	IL2
T61698	DI0361	Renal cell carcinoma	[ICD-11: 2C90]	P60568	IL2
T72038	DI0190	Hypertension	[ICD-11: BA00-BA04]	P17931	LGALS3
T72038	DI0199	Idiopathic interstitial pneumonitis	[ICD-11: CB03]	P17931	LGALS3
T72038	DI0252	Melanoma	[ICD-11: 2C30]	P17931	LGALS3
T72038	DI0302	Non-alcoholic fatty liver disease	[ICD-11: DB92]	P17931	LGALS3
T72038	DI0351	Psoriasis	[ICD-11: EA90]	P17931	LGALS3
T97035	DI0007	Acquired hypermelanosis	[ICD-11: ED60]	P14679	TYR
T97035	DI0008	Acquired hypomelanotic disorder	[ICD-11: ED63]	P14679	TYR